1. Home
  2. MRNA vs FHN Comparison

MRNA vs FHN Comparison

Compare MRNA & FHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • FHN
  • Stock Information
  • Founded
  • MRNA 2010
  • FHN 1864
  • Country
  • MRNA United States
  • FHN United States
  • Employees
  • MRNA N/A
  • FHN N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • FHN Major Banks
  • Sector
  • MRNA Health Care
  • FHN Finance
  • Exchange
  • MRNA Nasdaq
  • FHN Nasdaq
  • Market Cap
  • MRNA 10.3B
  • FHN 9.1B
  • IPO Year
  • MRNA 2018
  • FHN N/A
  • Fundamental
  • Price
  • MRNA $30.46
  • FHN $22.01
  • Analyst Decision
  • MRNA Hold
  • FHN Buy
  • Analyst Count
  • MRNA 19
  • FHN 17
  • Target Price
  • MRNA $48.13
  • FHN $22.26
  • AVG Volume (30 Days)
  • MRNA 9.3M
  • FHN 5.9M
  • Earning Date
  • MRNA 07-31-2025
  • FHN 07-16-2025
  • Dividend Yield
  • MRNA N/A
  • FHN 2.76%
  • EPS Growth
  • MRNA N/A
  • FHN N/A
  • EPS
  • MRNA N/A
  • FHN 1.44
  • Revenue
  • MRNA $3,177,000,000.00
  • FHN $3,043,000,000.00
  • Revenue This Year
  • MRNA N/A
  • FHN $11.15
  • Revenue Next Year
  • MRNA $9.70
  • FHN $3.91
  • P/E Ratio
  • MRNA N/A
  • FHN $15.10
  • Revenue Growth
  • MRNA N/A
  • FHN 3.43
  • 52 Week Low
  • MRNA $23.15
  • FHN $14.34
  • 52 Week High
  • MRNA $129.39
  • FHN $22.44
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 67.68
  • FHN 74.09
  • Support Level
  • MRNA $26.81
  • FHN $20.98
  • Resistance Level
  • MRNA $28.24
  • FHN $20.62
  • Average True Range (ATR)
  • MRNA 1.20
  • FHN 0.40
  • MACD
  • MRNA 0.43
  • FHN 0.19
  • Stochastic Oscillator
  • MRNA 91.84
  • FHN 98.18

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About FHN First Horizon Corporation

First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.

Share on Social Networks: